Lyka Labs and Kwality Pharmaceuticals Report Over 100% Net Profit Growth in June 2026 Quarter
Lyka Labs and Kwality Pharmaceuticals reported significant net profit increases in the quarter ended June 2026 compared to the same period in 2025. Lyka Labs' net profit rose 122.58% to Rs 2.07 crore with sales up 28.10% to Rs 42.31 crore. Kwality Pharmaceuticals' net profit increased 114.75% to Rs 25.62 crore, alongside a 45.63% rise in sales to Rs 162.35 crore. Both companies showed improved profitability and sales growth during this period.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (63/100). Lens Score 30/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (58–68/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 10 Aug, 08:39 am. Other outlets followed.